Akèy › Kansè bronch › Texas › Houston

Etid klinik pou Kansè bronch nan Houston, TX

5 etid pou Kansè bronch ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2

MD Anderson, Houston

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3

Houston Methodist Hospital, Houston
University of Texas MD Anderson Cancer Center, Houston
Lumi Research, Houston

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Ap rekriteFaz 3

The University of Texas MD Anderson Cancer Center, Houston

Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07185997

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2

MD Anderson Cancer Center, Houston

Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Ap rekrite

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761

Etid Kansè bronch nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.